Clinical trial
Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in…
NCT00062556 · Kos Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00062556 |
|---|---|
| Title | Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication |
| Official title | Effect of Niacin ER/Lovastatin on Peak Walking Time and Claudication Onset Time in Patients With Intermittent Claudication |
| Lead sponsor | Kos Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Intermittent Claudication, Peripheral Vascular Disease |
| Intervention type | Drug |
| Interventions | Niacin Extended Release and Lovastatin Tablets |
| Enrollment | 366 |
| Start date | Jan 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Jun 12, 2003 |
| Last update posted | Nov 1, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: